The Insights Report – Carbon Emissions

NEXTSTELLIS was approved by the Therapeutic Goods Administration in November 2021.

Genex's June quarterly report shows encouraging positive operating cashflow and a strong solar revenue.

Substantial investment is required to transition the electricity system to net zero emissions. So this is good news.